(Q35602154)

English

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies

scientific article published on December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

1 reference

Europe PubMed Central

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

Factor V Leiden

1 reference

based on heuristic

inferred from title

Prothrombin G20210A

1 reference

based on heuristic

inferred from title

author name string

Robert J Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Richard C Becker

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

948-957

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Clinical epidemiological quality in molecular genetic research: the need for methodological standards

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Prevalence of the prothrombin gene variant 20210 G --> A among patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Age as a risk factor for myocardial infarction in Leiden mutation carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Incidence of factor V Leiden in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

The 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Inherited thrombophilia in ischemic stroke and its pathogenic subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Methylenetetrahydrofolate reductase gene and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Female hormones and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Tissue factor in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Tissue factor pathway inhibitor levels in patients with homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900519-2

7 January 2021

Identifiers

10.1016/S0002-8703(03)00519-2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35602154&oldid=2049246297"